Do hallucinogens cause residual neuropsychological toxicity?
The DOI matches its Crossref record; 87 of the 90 references it cites were found in a registry or an index.
Abstract
We collected and reviewed studies in which neuropsychological tests were administered to users of LSD or other hallucinogens. Interpretation of the studies is limited by various confounding variables, such as subjects' premorbid cognitive and personality function and prior use of other substances. At present, the literature tentatively suggests that there are few, if any, long-term neuropsychological deficits attributable to hallucinogen use. To better resolve this issue, however, it will be important to study larger samples of chronic, frequent hallucinogen users who have not often used other types of drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,237
Shulgin, A. T., & Shulgin, A. (1991) · Cited by 668
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568 · cited 2×
“Much research is also being directed upon N-methyl-D-aspartate (NMDA) glutamate receptors (Coyle, 1996), since NMDA antagonists (notably including PCP and ketamine) can induce psychotic-like intoxications in man (Javitt and Zukin, 1991; Krystal et al.”
BackgroundPlants of the Gods: Their Sacred, Healing and Hallucinogenic Powers
Hofmann, A., & Schultes, R. E. (1992) · Medical Entomology and Zoology · Cited by 463
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
Strassman, R. J. (1984) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198410000-00001 · Cited by 312
LYSERGIC ACID DIETHYLAMIDE: SIDE EFFECTS AND COMPLICATIONS
COHEN, S. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196001000-00005 · Cited by 287
Research works printed but not linked: 9
- Abraham, 1998, Hallucinogens persisting perception disorder, Practical Rev. Psychiatry, 22, 1
- Cohen, G.H., Collins, H., Susmilch, C., 1974. Personality characteristics and social background of the lysergic acid diethylamide user. In: Singh, J.M. and Lal, H. (Eds.), Drug Addiction. Stratton, New York, pp. 263-271.
- Cohen, 1969, LSD and organic brain impairment, Drug Depend., 2, 1
- Duncan, 1970, LSD and intelligence: an exploratory study, Psychology, 7, 6
- Jacobs, 1987, How hallucinogenic drugs work, Am. Sci., 75, 386
- Kleckner, 1968, Personality differences between psychedelic drug users and nonusers, Psychology, 5, 66
- SAMHSA (Substance Abuse and Mental Health Services Administration), Office of Applied Studies, 1997. Trends in initiation of drug use. In: Preliminary Results From the 1996 National Household Survey on Drug Abuse. DHHS (SMA) 97-3149. National Clearinghouse for Alcohol and Drug Information, Rockville, MD, pp. 23-25.
- Stoll, 1947, Lysergsäure-diäthylamid, ein phantastikum aus der mutterkorngruppe [Lysergic acid diethylamide, a phantasticon of the ergot group], Scheizer Archiv fur Neurologie und Psychiatrie, 60, 1
- Thatcher, 1970, Personality trait dependent performance under psilocybin, Part II. Dis. Nerv. Sys., 31, 181
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Metadata
- Authors
- Halpern, J. H., & Pope, H. G.
- Affiliations
- Harvard University (US)
- McLean Hospital (US)
- Corresponding author
- Halpern, John H
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 53
- Issue
- 3
- Pages
- 247-256
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2112884745
- Cited by
- 82
- References
- 90
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 6 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heffter Research Institute
- National Institute on Drug Abuse (DA 07252, DA 10346, T32DA007252)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- hallucinogens, LSD, long-term cognitive deficits, chronic drug use, confounding variables, personality
- MeSH terms
- Adolescent, Adult, Chronic Disease, Cognition Disorders, Female, Hallucinogens, Humans, Lysergic Acid Diethylamide, Male, Middle Aged, Neuropsychological Tests, Personality Disorders, Serotonin, Severity of Illness Index, Time Factors, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do hallucinogens cause residual neuropsychological toxicity? https://app.cochat.ai/papers/10.1016/s0376-8716(98)00129-x
- The paper
- Halpern, J. H., & Pope, H. G. (1999). Do hallucinogens cause residual neuropsychological toxicity? Drug and Alcohol Dependence. https://doi.org/10.1016/s0376-8716(98)00129-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.